Hélène Regnault

3.2k total citations
26 papers, 683 citations indexed

About

Hélène Regnault is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Hélène Regnault has authored 26 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 10 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Hélène Regnault's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Hélène Regnault is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Hélène Regnault collaborates with scholars based in France, Italy and Germany. Hélène Regnault's co-authors include Giuliana Amaddeo, Julien Caldéraro, Alexis Laurent, Danièle Sommacale, Alain Luciani, Sebastien Mulé, Jean–Michel Pawlotsky, Marianne Ziol, Vania Tacher and Charlie Saillard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Hélène Regnault

24 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Regnault France 12 298 261 182 170 134 26 683
Ja‐Der Liang Taiwan 14 255 0.9× 74 0.3× 177 1.0× 129 0.8× 47 0.4× 37 625
Tobias Paul Seraphin Germany 8 131 0.4× 145 0.6× 108 0.6× 102 0.6× 76 0.6× 12 429
Tomohiro Minami Japan 17 758 2.5× 176 0.7× 359 2.0× 229 1.3× 71 0.5× 37 1.1k
Chee Leong Cheng Singapore 16 227 0.8× 57 0.2× 361 2.0× 193 1.1× 65 0.5× 36 1.0k
Kaiqian Zhou China 16 161 0.5× 210 0.8× 78 0.4× 222 1.3× 25 0.2× 35 850
Jo Ann Rinaudo United States 16 216 0.7× 72 0.3× 224 1.2× 284 1.7× 20 0.1× 27 692
Xiaoying Liu United States 15 43 0.1× 99 0.4× 186 1.0× 180 1.1× 114 0.9× 31 607
Shanshan Yin China 15 307 1.0× 133 0.5× 242 1.3× 201 1.2× 9 0.1× 58 853
Hiroaki Takeoka Japan 15 217 0.7× 47 0.2× 252 1.4× 228 1.3× 26 0.2× 43 738

Countries citing papers authored by Hélène Regnault

Since Specialization
Citations

This map shows the geographic impact of Hélène Regnault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Regnault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Regnault more than expected).

Fields of papers citing papers by Hélène Regnault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Regnault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Regnault. The network helps show where Hélène Regnault may publish in the future.

Co-authorship network of co-authors of Hélène Regnault

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Regnault. A scholar is included among the top collaborators of Hélène Regnault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Regnault. Hélène Regnault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouattour, Mohamed, Brice Fresneau, Anthony Turpin, et al.. (2025). Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohort. Digestive and Liver Disease. 57(7). 1495–1500.
2.
Sessa, Anna, Carlo Saitta, Julia Chalaye, et al.. (2024). Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy. Annals of Hepatology. 30(1). 101539–101539. 2 indexed citations
3.
Pais, Raluca, Lucile Moga, Christine Silvain, et al.. (2024). Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal Hypertension. Obesity Surgery. 35(2). 395–405. 1 indexed citations
4.
Lequoy, Marie, Giuliana Amaddeo, Isabelle Fouchard, et al.. (2024). MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis. JHEP Reports. 6(10). 101160–101160. 11 indexed citations
5.
Gigante, Elia, Mohamed Bouattour, Hélène Regnault, et al.. (2023). Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. Journal of Hepatology. 78. S577–S577. 1 indexed citations
6.
Gigante, Elia, Mohamed Bouattour, Josè Ursic‐Bedoya, et al.. (2023). Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study. United European Gastroenterology Journal. 12(4). 429–439. 4 indexed citations
7.
Zeng, Qinghe, Christophe Klein, Stefano Caruso, et al.. (2022). Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology. Journal of Hepatology. 77(1). 116–127. 72 indexed citations
8.
Brustia, Raffaele, Rami Rhaiem, Hélène Regnault, et al.. (2022). Liver resection for single large hepatocellular carcinoma: a prognostic factors study. Annals of Hepatology. 27(6). 100739–100739. 9 indexed citations
9.
Sessa, Anna, Sebastien Mulé, Raffaele Brustia, et al.. (2022). Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge. SHILAP Revista de lepidopterología. Volume 9. 661–670. 11 indexed citations
10.
Saillard, Charlie, Benoît Schmauch, Matahi Moarii, et al.. (2020). Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides. Hepatology. 72(6). 2000–2013. 200 indexed citations
11.
Ghosn, Marwan, Nadia Oubaya, Sebastien Mulé, et al.. (2020). Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagnostic and Interventional Imaging. 102(1). 35–44. 18 indexed citations
12.
13.
Mulé, Sebastien, Arthur Tenenhaus, Giuliana Amaddeo, et al.. (2020). Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma. Radiology. 295(3). 562–571. 104 indexed citations
14.
Saillard, Charlie, Benoît Schmauch, Matahi Moarii, et al.. (2020). Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides. Journal of Hepatology. 73. S381–S381. 14 indexed citations
15.
Meylan, Maxime, Florent Petitprez, Laetitia Lacroix, et al.. (2020). Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules. Clinical Cancer Research. 26(16). 4381–4389. 76 indexed citations
16.
Regnault, Hélène, Sheik Emambux, Thierry Lecomte, et al.. (2017). Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study. Digestive and Liver Disease. 50(3). 285–290. 8 indexed citations
17.
Lequoy, Marie, Hélène Regnault, Dominique Wendum, et al.. (2016). Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. Journal of Experimental & Clinical Cancer Research. 35(1). 126–126. 6 indexed citations
18.
Regnault, Hélène, Anne Bourrier, V. Lalande, et al.. (2014). Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: A retrospective assessment. Digestive and Liver Disease. 46(12). 1086–1092. 36 indexed citations
19.
Langrand, Jérôme, Hélène Regnault, Xavier Cachet, et al.. (2014). Toxic hepatitis induced by a herbal medicine: Tinospora crispa. Phytomedicine. 21(8-9). 1120–1123. 31 indexed citations
20.
Patrikidou, Anna, Isabelle Sinapi, Hélène Regnault, et al.. (2014). Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies. Investigational New Drugs. 32(5). 1028–1035. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ja‐Der Liang Breakdown of academic impact, for papers by Tobias Paul Seraphin Breakdown of academic impact, for papers by Tomohiro Minami Breakdown of academic impact, for papers by Chee Leong Cheng Breakdown of academic impact, for papers by Kaiqian Zhou Breakdown of academic impact, for papers by Jo Ann Rinaudo Breakdown of academic impact, for papers by Xiaoying Liu Breakdown of academic impact, for papers by Shanshan Yin Breakdown of academic impact, for papers by Hiroaki Takeoka
Rankless by CCL
2026